Daiqing Liao

2.9k citations
54 papers · 2.3k indexed · h-index 27
Topics
Histone Deacetylase Inhibitors Research (16 papers)Protein Degradation and Inhibitors (15 papers)Cancer-related Molecular Pathways (12 papers)
Partner nations
United StatesChinaCanada

In The Last Decade

Daiqing Liao

53 papers receiving 2.2k citations

Peers

Daiqing Liao
Comparison fields: 5 of 123
  • Molecular Biology 1.7k
  • Oncology 552
  • Genetics 388
  • Cancer Research 234
  • Plant Science 217
Replace Michael W. Van Dyke with:
Michael W. Van Dyke United States
Tamar Juven‐Gershon Israel
Hans van den Elst Netherlands
Tharan Srikumar Canada
Achim Dickmanns Germany
Shingo Nishikori Japan
Benoit Coulombe Canada
Thomas Albert Germany
Milton H. Werner United States
Kevin Blackburn United States
Daiqing Liao relative to Michael W. Van Dyke United States Michael W. Van Dyke's profile →
Citations per field
00.5×3.2×
Michael W. Van Dyke · 1×
Citations per year

Countries citing papers authored by Daiqing Liao

Since Specialization
Citations

This map shows the geographic impact of Daiqing Liao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daiqing Liao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daiqing Liao more than expected).

Fields of papers citing papers by Daiqing Liao

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daiqing Liao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daiqing Liao. The network helps show where Daiqing Liao may publish in the future.

Co-authorship network of co-authors of Daiqing Liao

This figure shows the co-authorship network connecting the top 25 collaborators of Daiqing Liao. A scholar is included among the top collaborators of Daiqing Liao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Daiqing Liao. Daiqing Liao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 1
2 8
3 20
4 21
5 90
6 46
7 1
8 82
9 12
10 77
11 32
12 8
13 49
14 24
15 298
16 23
17 26
18 70
19 35
20 24

About Daiqing Liao

Daiqing Liao is a scholar working on Oncology, Biotechnology and Molecular Biology, having authored 54 papers that have together received 2.3k indexed citations. Recurring topics across this work include Histone Deacetylase Inhibitors Research (16 papers), Protein Degradation and Inhibitors (15 papers) and Cancer-related Molecular Pathways (12 papers). The work is most often cited by research in Molecular Biology (1.7k citations), Oncology (552 citations) and Cancer Research (234 citations). Daiqing Liao has collaborated with scholars based in United States, China and Canada. Frequent co-authors include Lisa Zhao, Iqbal Mahmud, Alan M. Weiner, Patrick P. Dennis, April Colosimo, Yue Liu, Dorothy Markowitz, He Zhou, R. Reisfeld and Rong Xiang. Their work appears in journals such as Nucleic Acids Research, Journal of Biological Chemistry and The EMBO Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026